These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
489 related items for PubMed ID: 15481288
1. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Kelley ST, Bloomston M, Serafini F, Carey LC, Karl RC, Zervos E, Goldin S, Rosemurgy P, Rosemurgy AS. Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288 [Abstract] [Full Text] [Related]
3. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection. Hernandez J, Cowgill SM, Al-Saadi S, Villadolid D, Ross S, Kraemer E, Shapiro M, Mullinax J, Cooper J, Goldin S, Zervos E, Rosemurgy A. Ann Surg Oncol; 2008 Mar; 15(3):807-14. PubMed ID: 18181000 [Abstract] [Full Text] [Related]
5. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM. Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638 [Abstract] [Full Text] [Related]
6. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H. Cancer; 2003 Jun 01; 97(11):2783-90. PubMed ID: 12767091 [Abstract] [Full Text] [Related]
8. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma]. Liang JW, Zhao P, Zhou ZX, Tian YT, Zhao DB, Wang CF. Zhonghua Wai Ke Za Zhi; 2009 May 01; 47(9):677-80. PubMed ID: 19615237 [Abstract] [Full Text] [Related]
9. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Cancer; 2005 Mar 15; 103(6):1210-6. PubMed ID: 15685618 [Abstract] [Full Text] [Related]
10. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Ann Surg Oncol; 2008 Oct 15; 15(10):2787-94. PubMed ID: 18685896 [Abstract] [Full Text] [Related]
12. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Endo I, House MG, Klimstra DS, Gönen M, D'Angelica M, Dematteo RP, Fong Y, Blumgart LH, Jarnagin WR. Ann Surg Oncol; 2008 Aug 15; 15(8):2104-12. PubMed ID: 18543039 [Abstract] [Full Text] [Related]
14. Our experiences in surgical treatment for hilar cholangiocarcinoma. Maeno H, Ono T, Yamanoi A, Nagasue N. Hepatogastroenterology; 2007 Aug 15; 54(75):669-73. PubMed ID: 17591038 [Abstract] [Full Text] [Related]
16. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Nozawa S. Surgery; 2007 May 15; 141(5):581-8. PubMed ID: 17462457 [Abstract] [Full Text] [Related]
17. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Rea DJ, Munoz-Juarez M, Farnell MB, Donohue JH, Que FG, Crownhart B, Larson D, Nagorney DM. Arch Surg; 2004 May 15; 139(5):514-23; discussion 523-5. PubMed ID: 15136352 [Abstract] [Full Text] [Related]
20. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis]. Ramacciato G, Di Benedetto F, Cautero N, Masetti M, Mercantini P, Corigliano N, Nigri G, Lauro A, Ercolani G, Del Gaudio M, De Ruvo N, Pinna AD. Chir Ital; 2004 May 15; 56(6):749-59. PubMed ID: 15771027 [Abstract] [Full Text] [Related] Page: [Next] [New Search]